Cory Sago, currently CEO at Stealth Biotech Company, is an entrepreneur and drug delivery expert who co-founded and served as CTO of Guide Therapeutics, pioneering high-throughput discovery of lipid nanoparticles for RNA delivery, until its acquisition by Beam Therapeutics where he then led LNP Discovery.Â
With a PhD in Biomedical Engineering and MS in Chemistry, Dr. Sago leverages cross-disciplinary expertise in chemistry, biology, and immunology to advance innovative technologies, co-inventing numerous patents and co-founding startups focused on pushing scientific boundaries to solve complex human diseases.
As a proven team and company builder at the intersection of cutting-edge science and technology, he brings invaluable leadership transforming disruptive ideas into products and treatments that better human health.
